BWAYBrainsWay Ltd.
Is the business good?
The checks split: nothing decisive, though earnings fully cash-backed (4.1×).
Operating profit is fully backed by cash. Conversion is worsening vs a year ago.
Margins have held roughly steady, a stable cost structure.
A balanced mix of margins, efficiency, and leverage. ROE 10% = margin × turnover × leverage.
Unless marked, from derived.
Where this answer is blind. The F-score rewards improvement, so an already-elite company can score mid-pack.
How good a business is BWAY?
BrainsWay Ltd. keeps 8.3% of every revenue dollar as operating profit, against 0.61% for the median Medical Devices name.
Operating margin · Medical Devices median 0.61% · fiscal year to FY2025
- Cash conversion
- 4.12×
Cash conversion · 8.77× a year ago · operating cash flow covers the operating profit after tax
- Share count, year on year
- +12%
Share count, year on year · shareholders own a smaller slice than a year ago
- R&D as % of revenue
- 18%
R&D as % of revenue
| Year | Operating margin |
|---|---|
| FY2020 | −22% |
| FY2021 | −17% |
| FY2022 | −47% |
| FY2023 | −16% |
| FY2024 | 3.4% |
| FY2025 | 8.3% |
Details›
- Gross marginfiscal year to FY2025
- 75%
- Operating marginfiscal year to FY2025
- 8.3%
- Net marginfiscal year to FY2025
- 14%
- R&D as % of revenue
- 18%
- Revenue, trailing twelve months
- $52M
- Net income, trailing twelve months
- $7.6M
Margins, capital and share counts from the statements as filed with the SEC; cash conversion is operating cash flow over operating profit after tax.